Get started
Author

Kirsten Leeten

Observed name: Leeten, Kirsten
ORCID: 0000-0001-9153-2093
Observed ORCID: 0000-0001-9153-2093
OpenAlex ID: A5050348079
Aspirin or Ticagrelor in Staphylococcus aureus Infective Endocarditis: Where Do We Stand?
2021 · Kirsten Leeten, Nicolas Jacques, et al. · Frontiers in Cell and Developmental Biology · 19
PDF
Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice
2023 · Cécile Oury, Severien Meyers, et al. · JACC Basic to Translational Science · 15
PDF
A Clinically Selected Staphylococcus aureus clpP Mutant Survives Daptomycin Treatment by Reducing Binding of the Antibiotic and Adapting a Rod-Shaped Morphology
2023 · Lijuan Xu, Camilla Henriksen, et al. · Antimicrobial Agents and Chemotherapy · 13
Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance
2024 · Kirsten Leeten, Nicolas Jacques, et al. · mBio · 10
Staphylococcus aureusadheres avidly to decellularised cardiac homograft tissue in vitro in the fibrinogen-dependent manner
2020 · Bartosz Ditkowski, Kirsten Leeten, et al. · Cardiology in the Young · 4
An In Vitro Model to Study Endothelialization of Cardiac Graft Tissues Under Flow
2021 · Kirsten Leeten, Bartosz Ditkowski, et al. · Tissue Engineering Part C Methods · 3
PDF
Novel determinant of antibiotic resistance: a clinically selected Staphylococcus aureus clpP mutant survives daptomycin treatment by reducing binding of the antibiotic and adapting a rod-shaped morphology
2023 · Lijuan Xu, Camilla Henriksen, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Ticagrelor prevents infective endocarditis by mitigating Staphylococcus aureus virulence
2022 · Nicolas Jacques, Severien Meyers, et al. · Archives of Cardiovascular Diseases Supplements
PDF
Works count: 15
Citation count: 66
H-index: 4
I10-index: 4
Year
Topic
Type